Views
1 year ago

2020 Annual Report

  • Text
  • Scientists
  • Education
  • Michigan
  • Epigenetics
  • Vai
  • Institute
  • Virtual
This is the 2020 Annual Report for Van Andel Institute.

Van Andel Institute

Van Andel Institute Board Members Van Andel Institute Trustees David Van Andel Chairman & Chief Executive Officer, Van Andel Institute Joan Budden Former President & Chief Executive Officer, Priority Health John Kennedy President & Chief Executive Officer, Autocam Medical Mark Meijer Founder & President, Life E.M.S. Ambulance Van Andel Research Institute Trustees David Van Andel Chairman & Chief Executive Officer, Van Andel Institute Tom R. DeMeester, M.D. Professor & Chairman Emeritus, Department of Surgery, Keck School of Medicine, University of Southern California James B. Fahner, M.D. Chief of Hematology & Oncology, Helen DeVos Children’s Hospital Michelle Le Beau, Ph.D. Professor of Medicine, Section of Hematology/Oncology; Director, University of Chicago Comprehensive Cancer Center; Director, Cancer Cytogenetics Laboratory, University of Chicago George Vande Woude, Ph.D. Distinguished Scientific Fellow, Emeritus; Founding Research Director, Van Andel Institute Max S. Wicha, M.D. Distinguished Professor of Oncology; Professor, Department of Internal Medicine; Founding Director, University of Michigan Comprehensive Cancer Center Van Andel Education Institute Trustees David Van Andel Chairman & Chief Executive Officer, Van Andel Institute James E. Bultman, Ed.D. President Emeritus, Hope College Susan Keipper Meell Chief Executive Officer, MMS Education Juan R. Olivarez, Ph.D. Distinguished Scholar in Residence for Diversity, Equity & Inclusion, Dorothy A. Johnson Center for Philanthropy, Grand Valley State University; President Emeritus, Aquinas College Teresa Weatherall Neal, Ed.D. (hon) Former Superintendent, Grand Rapids Public Schools (LEFT TO RIGHT) JOHN KENNEDY, DAVID VAN ANDEL, MARK MEIJER & JOAN BUDDEN 48 | VAN ANDEL INSTITUTE ANNUAL REPORT 2020

BOARDS Van Andel Institute Graduate School Board of Directors James B. Fahner, M.D. Division Chief of Pediatric Hematology/Oncology & Senior Administrative Physician for Philanthropy & Community Relations at Helen DeVos Children’s Hospital Peter A. Jones, Ph.D., D.Sc. (hon) Chief Scientific Officer, Van Andel Institute Pamela Kidd, M.D. Medical Medical Director, Hematology & Flow Cytometry Laboratories of Spectrum Health & Helen DeVos Children’s Hospital Karen Klomparens, Ph.D. Vice Chair; Former Dean of the Graduate School & Associate Provost for Graduate Education, Michigan State University Juan R. Olivarez, Ph.D. Chairman of the Board; Distinguished Scholar in Residence for Diversity, Equity & Inclusion, Dorothy A. Johnson Center for Philanthropy, Grand Valley State University; President Emeritus, Aquinas College Mary O’Riordan, Ph.D. Associate Dean of Graduate & Postdoctoral Studies and Frederick C. Neidhardt Collegiate Professor of Microbiology and Immunology, University of Michigan Medical School Danny R. Welch, Ph.D. Founding Chair, Department of Cancer Biology, University of Kansas Cancer Center Van Andel Research Institute External Scientific Advisory Board Sharon Y.R. Dent, Ph.D. (ESAB Chair) Professor & Chair, Department of Epigenetics & Molecular Carcinogenesis; Director, Science Park; Director, Center for Cancer Epigenetics, MD Anderson Cancer Center Xiaodong Cheng, Ph.D. Professor, The University of Texas MD Anderson Cancer Center, Department of Molecular & Cellular Oncology Joseph Ecker, Ph.D. Professor, Plant Molecular & Cellular Biology Laboratory; Director, Genomic Analysis Laboratory, Salk Institute; Howard Hughes Medical Institute Investigator Theresa Guise, M.D. Professor Department of Endocrine Neoplasia & Hormonal Disorders; Chief, Section of Bone & Mineral Disorders at The University of Texas MD Anderson Cancer Center; Cancer Prevention Research Institute of Texas (CPRIT) Scholar; Co-Director, The Rolanette & Berdon Lawrence Bone Disease Program of Texas​; Co-Leader, Tumor Microenvironment & Metastasis program of the IU Simon Cancer Center, NCI Comprehensive Cancer Center Tony Hunter, Ph.D. Professor, Molecular & Cell Biology Laboratory; American Cancer Society Professor; Renato Dulbecco Chair; Director, Salk Institute Cancer Center Anthony E. Lang, M.D. Senior Scientist, Krembil Research Institute Mitchell Lazar, M.D., Ph.D. Willard & Rhoda Ware Professor in Diabetes & Metabolic Diseases, Perelman School of Medicine, University of Pennsylvania Thomas J. Montine, M.D., Ph.D. Professor, Pathology, Stanford University Max S. Wicha, M.D. Distinguished Professor of Oncology; Professor, Department of Internal Medicine; Founding Director, University of Michigan Comprehensive Cancer Center VAN ANDEL INSTITUTE ANNUAL REPORT 2020 | 49

Publications by Year